Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by hvaron Sep 12, 2011 9:36am
356 Views
Post# 19032145

News Release (Warrants Exercised)

News Release (Warrants Exercised)
100% of expiring warrants exercised for proceeds of $13.9 MM
TSX: GPD
www.goldenpredator.com
VANCOUVER, Sept. 12, 2011 /PRNewswire/ - Golden Predator Corp. (TSX:GPD) (the "Company") is pleased to announce the following share purchase warrant exercises:
Expiry Date
Number of 
Warrants
Exercise Price
Net Proceeds
Per Cent 
Exercised
August 16, 2011
   3,092,000
.80
$2,473,600
100%
August 21, 2011
      100,000
.90
$90,000
100%
September 9, 2011
13,471,429
.84
$11,316,000
100%
 
 
 
$13,879,600
 
Golden Predator Chairman & Chief Executive Officer William M. Sheriff said: "With the $13.9 MM realized from the exercise of these warrants, and the $5.75 MM received on the sale of our Tonkin Spring interest to US Gold in July, our treasury now sits at $30.1 MM in cash and equivalents.  These funds are sufficient to meet our anticipated exploration needs through the remainder of 2011 and all of 2012, as we continue the strategic development of our Yukon assets."
About Golden Predator Corp.
Golden Predator Corp., Yukon's Gold Company, is a well-funded exploration company mandated to create a mid-tier gold producer.  Golden Predator's road-accessible advanced properties include its flagship Brewery Creek Project on which the Company is moving aggressively to a near term production decision, as well as its Grew Creek and Clear Creek Projects.
Golden Predator has the largest controlled land position in the Yukon, with exploration holdings in excess of 1,400,000 acres (over 5,700 km2), and is committed to strong relationships with Yukon communities and First Nations.  Golden Predator's management and technical teams continue to lead aggressive exploration programs in the underexplored region of the Yukon, and are driven to bring value to shareholders and leave a positive legacy in the Yukon.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance. There are numerous risks and uncertainties that could cause actual results and Golden Predator's plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, Golden Predator assumes no obligation to update forward-looking information should circumstances or management's estimates or opinions change. 
SOURCE Golden Predator Corp.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse